Low & Anaplastic Grade Glioma Umbrella Study of MOlecular Guided TherapieS (LUMOS-2): study protocol for a phase 2, prospective, multicentre, open-label, multiarm, biomarker-directed, signal-seeking, umbrella, clinical trial for recurrent IDH mut
Low & Anaplastic Grade Glioma Umbrella Study of MOlecular Guided TherapieS (LUMOS-2): study protocol for a phase 2, prospective, multicentre, open-label, multiarm, biomarker-directed, signal-seeking, umbrella, clinical trial for recurrent IDH mut
Sonia Yip, Hui Kong Gan, Eng‐Siew Koh, Lucille Sebastian et al.
Citations
2 citations
Journal
BMJ Open
Topics
Glioma Diagnosis and Treatment
Field-Weighted Citation Impact (FWCI)
3.25
article
Low & Anaplastic Grade Glioma Umbrella Study of MOlecular Guided TherapieS (LUMOS-2): study protocol for a phase 2, prospective, multicentre, open-label, multiarm, biomarker-directed, signal-seeking, umbrella, clinical trial for recurrent IDH mut
Sonia Yip, Hui Kong Gan, Eng‐Siew Koh, Lucille Sebastian, Elizabeth Helen Barnes, Hao‐Wen Sim, Marshall Pitz, Benjamin Y. Kong, Christopher O’Callaghan, Subotheni Thavaneswaran, David M. Thomas, John Simes, Desma Spyridopoulos, Mandy L. Ballinger, Richard De Abreu Lourenço, Patrick J Wheeler, Cynthia Hawkins, Kristen McParland
article en
2 citations
Abstract
No abstract available for this paper.
Publication Tag
BMJ OpenVol. 15(2)
Institutions
University of Technology Sydney (AU), The University of Sydney (AU), University of Toronto (CA), Queen's University (CA), Liverpool Hospital (AU), Hospital for Sick Children (CA), UNSW Sydney (AU), St Vincent's Hospital Sydney (AU), Chris O’Brien Lifehouse (AU), Prince of Wales Hospital (AU), SickKids Foundation (CA), The Kinghorn Cancer Centre (AU), Olivia Newton-John Cancer Wellness & Research Centre (AU), National Health and Medical Research Council (AU), University of Manitoba (CA)